Literature DB >> 25307214

Functional expression of drug transporters in glial cells: potential role on drug delivery to the CNS.

Tamima Ashraf1, Amy Kao1, Reina Bendayan2.   

Abstract

Drug permeability in the central nervous system (CNS) across blood-brain and blood-cerebrospinal fluid barriers is an important determinant of neurological disorders therapeutic efficacy and is highly regulated by the expression of membrane-associated transporters belonging to the ATP-binding cassette (ABC) and solute carrier (SLC) superfamilies. Functional expression of ABC efflux transporters exists not only at the brain barriers (primary biochemical barrier) but also in astrocytes, microglia, neurons, and oligodendrocytes can significantly restrict drug penetration into these cells, thus creating a secondary biochemical barrier to permeability in brain parenchyma. In contrast, SLC members primarily contribute to the uptake of endogenous substrates (i.e., hormones, neurotransmitters) and pharmacological agents and can play a critical role in maintaining CNS homeostasis and drug response. In this chapter, we review the functional expression and localization of drug transporters in the brain, their role in CNS drug delivery, and their regulation in neuropathological conditions.
© 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ABC transporters; Brain barriers; Brain drug permeability; Brain parenchyma; Neurological disorders; SLC transporters; Transporter regulation

Mesh:

Substances:

Year:  2014        PMID: 25307214     DOI: 10.1016/bs.apha.2014.06.010

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN: 1054-3589


  10 in total

1.  In-depth neuropharmacokinetic analysis of antipsychotics based on a novel approach to estimate unbound target-site concentration in CNS regions: link to spatial receptor occupancy.

Authors:  I Loryan; E Melander; M Svensson; M Payan; F König; B Jansson; M Hammarlund-Udenaes
Journal:  Mol Psychiatry       Date:  2016-01-26       Impact factor: 15.992

Review 2.  Drug transporters in the central nervous system.

Authors:  Bruno Stieger; Bo Gao
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

3.  ATP-binding Cassette Subfamily C Member 5 (ABCC5) Functions as an Efflux Transporter of Glutamate Conjugates and Analogs.

Authors:  Robert S Jansen; Sunny Mahakena; Marcel de Haas; Piet Borst; Koen van de Wetering
Journal:  J Biol Chem       Date:  2015-10-29       Impact factor: 5.157

4.  Astrocytes drive upregulation of the multidrug resistance transporter ABCB1 (P-Glycoprotein) in endothelial cells of the blood-brain barrier in mutant superoxide dismutase 1-linked amyotrophic lateral sclerosis.

Authors:  Hisham Qosa; Jessica Lichter; Mark Sarlo; Shashirekha S Markandaiah; Kevin McAvoy; Jean-Philippe Richard; Michael R Jablonski; Nicholas J Maragakis; Piera Pasinelli; Davide Trotti
Journal:  Glia       Date:  2016-05-09       Impact factor: 7.452

5.  The Prevention and Reversal of a Phenytoin-Resistant Model by N-acetylcysteine Therapy Involves the Nrf2/P-Glycoprotein Pathway at the Blood-Brain Barrier.

Authors:  Qiankun Liu; You Wang; Dandan Tan; Yong Liu; Peng Zhang; Limin Ma; Minxue Liang; Yangmei Chen
Journal:  J Mol Neurosci       Date:  2022-08-26       Impact factor: 2.866

6.  Localization of Xenobiotic Transporters Expressed at the Human Blood-Testis Barrier.

Authors:  Raymond K Hau; Robert R Klein; Stephen H Wright; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2022-03-20       Impact factor: 3.579

Review 7.  Transporters as Drug Targets in Neurological Diseases.

Authors:  H Qosa; L A Mohamed; S Alqahtani; B S Abuasal; R A Hill; A Kaddoumi
Journal:  Clin Pharmacol Ther       Date:  2016-08-27       Impact factor: 6.875

8.  Brain Distribution of Drugs: Brain Morphology, Delivery Routes, and Species Differences.

Authors:  Fanchon Bourasset; Sylvain Auvity; Robert G Thorne; Jean-Michel Scherrmann
Journal:  Handb Exp Pharmacol       Date:  2022

Review 9.  Targeting Transporters for Drug Delivery to the Brain: Can We Do Better?

Authors:  Elena Puris; Gert Fricker; Mikko Gynther
Journal:  Pharm Res       Date:  2022-03-31       Impact factor: 4.580

Review 10.  Drug-Resistant Epilepsy: Multiple Hypotheses, Few Answers.

Authors:  Fei Tang; Anika M S Hartz; Björn Bauer
Journal:  Front Neurol       Date:  2017-07-06       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.